A Day Up For Mainz Biomed B.V.

Wed, Oct 09, 2024 at 07:28 PM

Mainz Biomed B.V. (MYNZ:NASDAQ) soared at $0.38, representing a gain of 29.8%. On Wed, Oct 09, 2024, MYNZ:NASDAQ touched a New 2-Week High of $0.38. The stock got featured on our News Catalysts scanner on Tue, Oct 08, 2024 at 10:13 AM in the 'PATNERSHIP' category. From Wed, Sep 25, 2024, the stock recorded 70.00% Up Days and 54.55% Green Days

About Mainz Biomed B.V. (MYNZ:NASDAQ)

Mainz Biomed BV is engaged in developing molecular genetic diagnostic solutions for life-threatening conditions.

Top 10 Gainers:

Reneo Pharmaceuticals Inc. (RPHM:NASDAQ), 952.02%
Momentus Inc. (MNTS:NASDAQ), 155.42%
Banzai International, Inc. Class A Common Stock (BNZI:NASDAQ), 81.88%
Lee Enterprises Incorporated (LEE:NASDAQ), 46.78%
WW International, Inc. (WW:NASDAQ), 37.93%
Kaixin Auto Holdings (KXIN:NASDAQ), 37.22%
Surf Air Mobility Inc. (SRFM:NYSE), 30.9%
Arcadium Lithium plc (ALTM:NYSE), 30.9%
Mainz Biomed B.V. (MYNZ:NASDAQ), 29.76%
Nuwellis Inc. (NUWE:NASDAQ), 29.27%